Covestor’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Covestor's AMPH Position: Q2 2026 in Review
Covestor increased its Amphastar Pharmaceuticals (AMPH) stake by 76% in Q2 2026, buying an estimated $565 and bringing the position to 65 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2030.
Covestor first reported a position in AMPH in Q4 2021 and has held it in 19 quarters since. The position peaked at $90K in Q3 2023. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- Covestor held 65 shares of Amphastar Pharmaceuticals worth $1K as of Q2 2026.
- Covestor bought 28 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $565.
- Amphastar Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2030 holding.
- Covestor first reported a position in Amphastar Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
- Covestor's Amphastar Pharmaceuticals position peaked at $90K in Q3 2023.
- 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.